RNAseq analysis reveals transcriptome changes associated with the progression of non-alcoholic liver disease in livers from Efcab4b knockout mice

Chew W Cheng,Lucia Pedicini,Cintli Morales,Fenia Deligianni,Niamh Forde,Lynn McKeown
DOI: https://doi.org/10.1101/2024.05.13.593681
2024-05-15
Abstract:EFCAB4B is an evolutionarily conserved protein that encodes for the Rab GTPase Rab46, and the CRAC channel modulator, CRACR2A. Previous genome wide association studies have demonstrated the association of EFCAB4B variants in the progression of non-alcoholic liver disease (NAFLD). In this study we show that mice with global depletion of Efcab4b-/- have significantly larger livers than their wild-type (WT) counterparts. We performed RNA-sequencing (RNA-seq) analysis with liver tissues to investigate differential global gene expression among Efcab4b-/- and WT mice. Of the 69 differentially expressed genes (DEGs), analyses of biological processes found significant enrichment in liver and bile development, with 6 genes (Pck1, Aacs, Onecut1, E2f8, Xbp1, and Hes1) involved in both processes. Specific consideration of possible roles of DEGs or their products in NAFLD progression to (NASH) and hepatocarcinoma (HCC), demonstrated DEGs in the livers of Efcab4b-/- mice had roles in molecular pathways including lipid metabolism, inflammation, ER stress, and fibrosis. The results in this study provide additional insights into molecular mechanisms responsible for increasing susceptibility of liver injuries associated with EFCAB4B.
Genetics
What problem does this paper attempt to address?
The problem this paper attempts to address is the investigation of the impact of Efcab4b gene deletion on the progression of non-alcoholic fatty liver disease (NAFLD). Specifically, the study analyzed the differentially expressed genes (DEGs) between Efcab4b gene knockout mice (Efcab4b-/-) and wild-type mice (WT) liver tissues through RNA sequencing, in order to reveal the potential roles of these DEGs in liver development, lipid metabolism, inflammatory response, and fibrosis processes. The research findings provide new insights into how EFCAB4B variations increase susceptibility to liver injury.